Company Overview and News


Add 2196
to your dashboard

Headline News

News Live: Amit Shah appears in Guj HC as witness in Naroda Gam riot case

2017-09-18 moneycontrol
The United States seeks a peaceful resolution but is prepared to use military force if diplomatic efforts fail to end the nuclear standoff with North Korea, reports Bloomberg. “If our diplomatic efforts fail, though, our military option will be the only one left,” Secretary of State Rex Tillerson said. “But be clear: we seek a peaceful solution to this.” President Donald Trump, in a Sunday tweet, mocked North Korean leader Kim Jong Un as “Rocket Man. (8-0)

News Live: Sikka loyalist Infosys Senior VP Sanjay Rajagopalan resigns

2017-09-18 moneycontrol
The United States seeks a peaceful resolution but is prepared to use military force if diplomatic efforts fail to end the nuclear standoff with North Korea, reports Bloomberg. “If our diplomatic efforts fail, though, our military option will be the only one left,” Secretary of State Rex Tillerson said. “But be clear: we seek a peaceful solution to this.” President Donald Trump, in a Sunday tweet, mocked North Korean leader Kim Jong Un as “Rocket Man. (11-0)

News Live: India to replace China as growth engine

2017-09-18 moneycontrol
The United States seeks a peaceful resolution but is prepared to use military force if diplomatic efforts fail to end the nuclear standoff with North Korea, reports Bloomberg. “If our diplomatic efforts fail, though, our military option will be the only one left,” Secretary of State Rex Tillerson said. “But be clear: we seek a peaceful solution to this.” President Donald Trump, in a Sunday tweet, mocked North Korean leader Kim Jong Un as “Rocket Man. (12-0)

News Live: Fosun to buy 74% in Gland Pharma for $1.1bn

2017-09-18 moneycontrol
China's Fosun Group has agreed to tweak its buyout deal with the promoters of Hyderabad-based Gland Pharma and acquire 74% of the company for USD 1.1 billion. This transaction had earlier been on hold for over a year due to regulatory hurdles. Last July, Shanghai Fosun had agreed to buy 86% of the generic injectables firm from its shareholders but was not cleared by the Cabinet Committee of Economic Affairs. (4-0)

Shanghai Fosun to Buy Smaller Stake in Indian Drugmaker to Avoid Government Veto - Bloomberg

2017-09-18 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (164-3)

Two HNA deals hit hurdles as China tightens scrutiny: sources

2017-08-01 in.reuters
HONG KONG (Reuters) - At least two of HNA Group's overseas deals have hit a hurdle as the Chinese conglomerate struggles to take money out of China, said four people familiar with the process, amid a widening crackdown by Beijing on debt-fueled corporate acquisitions.

India likely to block $1.3 bn Gland Pharma-Fosun deal

2017-08-01 thehindubusinessline
India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group's proposed $1.3 billion takeover of Indian drugmaker Gland Pharma, a source familiar with the matter said on Monday.

India raises concerns around Chinese firm Fosun#39;s takeover of Gland: Source

2017-08-01 moneycontrol
India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group's proposed $1.3 billion takeover of Indian drugmaker Gland Pharma, a source familiar with the matter said on Monday.

UPDATE 1-India raises concerns around Chinese firm Fosun's takeover of Gland-source

2017-07-31 reuters
(Reuters) - India has privately raised objections to Chinese firm Shanghai Fosun Pharmaceutical Group's (600196.SS) proposed $1.3 billion takeover of Indian drugmaker Gland Pharma, a source familiar with the matter said on Monday.

India set to block $1.3 billion Gland Pharma-Fosun deal: Bloomberg

2017-07-31 in.reuters
(Reuters) - India's Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, has decided to block China's Shanghai Fosun Pharmaceutical Group Co's (600196.SS) proposed $1.3 billion takeover of Indian drugmaker Gland Pharma Ltd, Bloomberg reported, citing people familiar with the matter.

FIPB holds up Gland Pharmas acquisition by Chinese firm

2017-03-25 indiainfoline
The Foreign Investment and Promotion Board (FIPB) has postponed Gland Pharma’s deal with a Chinese firm, Shanghai Fosun, amounting to $1.4 billion.

FIPB Defers Gland Pharma's Acquisition by Chinese Firm

2017-03-24 business-standard
The Foreign Investment and Promotion Board (FIPB) has deferred the Gland Pharma-Shanghai Fosun deal worth $1.4 billion.

Big Deal: Know who's making news on Deal Street

2016-08-01 moneycontrol
Big Deal throws more light on large transactions that have been announced in India and overseas; a Chinese firm, Shanghai Fosun set to acquire 86 percent stake in Gland Pharma for over USD 1.3 billion; Yahoo sells its web business to Verizon for just under USD 5 billion and Flipkart's Myntra pips Snapdeal.

China's Fosun Just Paid $1.4 Billion for This KKR-Backed Company - Fortune

2016-07-29 fortune
Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma – backed by KKR & Co LP – for about $1.4 billion, a person with direct knowledge of the matter said, in India’s largest inbound acquisition this year.

Shanghai Fosun to pick 86% in Gland Pharma for $1.3 b

2016-07-28 thehindubusinessline
In one of the biggest acquisition by a Chinese company in India, Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy 86 per cent in Gland Pharma for about $1.3 billion. Gland Pharma, backed by private equity firm KKR & Co LP, has a strong portfolio in injectable drugs. The deal overtakes investments made by Chinese e-commerce giant Alibaba in India’s booming online retail sector.